CNTB Projected Dividend Yield
ADS/Connect Biopharma Holdings Ltd ( NASDAQ : CNTB )Connect Biopharma is a clinical-stage biopharmaceutical company developing therapies for the treatment of T cell-driven inflammatory diseases. Co.'s core expertise is in the use of functional cellular assays with T cells to screen and discover potent product candidates against immune targets. Co.'s two most advanced clinical-stage programs include highly differentiated product candidates against validated targets. Co.'s product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis, or AD, and asthma. 20 YEAR PERFORMANCE RESULTS |
CNTB Dividend History Detail CNTB Dividend News CNTB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |